HoiYChanMD

PubMed

• p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients.
  Siu, M. K., Chan, H. Y., Kong, D. S., Wong, E. S., Wong, O. G., Ngan, H. Y., Tam, K. F., Zhang, H., Li, Z., Chan, Q. K., Tsao, S. W., Strömblad, S., Cheung, A. N.> ;Proc Natl Acad Sci U S A. 2010 Oct 26
• Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.
  Siu, M.Y., Wong, E.Y., Chan, H.Y., Kong, D.H., Woo, N.S., Tam, K.F., Ngan, H.S., Chan, Q.Y., Chan, D.W., Chan, K.K., Cheung, A.Y.> ;Int J Cancer. 2010-07-01
• 5 citations
  Emergency Department Activation of Interventional Cardiology to Reduce Door-to-Balloon Time.
  Simon A. Mahler, Hoi Y. Chan, Donna L. Carden, Christopher J Wolcott, Steven A. Conrad> ;The Western Journal of Emergency Medicine. 2010 Sep 1
• Aberrant activation of hedgehog signaling pathway contributes to endometrial carcinogenesis through beta-catenin.
  Liao, X., Siu, M.Y., Au, C.H., Chan, Q.Y., Chan, H.Y., Wong, E.Y., Ip, P.C., Ngan, H.S., Cheung, A.Y.> ;Mod Pathol. 2009 Jun
• Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome.
  Siu, M.Y., Wong, E.Y., Chan, H.Y., Ngan, H.S., Chan, K.K., Cheung, A.Y.> ;Am J Pathol. 2008 Oct
• 7 citations
  Tamoxifen and estrogen attenuate enhanced vascular reactivity induced by estrogen deficiency in rat carotid arteries.
  Suk Ying Tsang, Xiaoqiang Yao, Hoi Yun Chan, Franky L. Chan, Cecilia S. Leung, Lai Ming Yung, CL Au, Zhen-Yu Chen, Ismail Laher, Yu Huang> ;Biochemical Pharmacology. 2007 May 1
• 91 citations
  Hypoxia-Inducible Factor-1-Mediated Activation of Stanniocalcin-1 in Human Cancer Cells
  HY Yeung, Keng Po Lai, Hoi Y. Chan, Nai Ki Mak, Graham F. Wagner, Chris K C Wong> ;Endocrinology. 2005 Nov 1
• 25 citations
  Contribution of K+ channels to relaxation induced by 17beta-estradiol but not by progesterone in isolated rat mesenteric artery rings.
  Suk Ying Tsang, Xiaoqiang Yao, Hoi Yun Chan, Chi Ming Wong, Zhen-Yu Chen, CL Au, Yu Huang> ;Journal of Cardiovascular Pharmacology. 2003 Jan 1
• 7 citations
  Isoproterenol amplifies 17β-estradiol-mediated vasorelaxation: role of endothelium/nitric oxide and cyclic AMP
  Hoi Yun Chan, Xiaoqiang Yao, Suk Ying Tsang, Jean-Pierre Bourreau, Franky L. Chan, Yu Huang> ;Cardiovascular Research. 2002 Feb 15
• Recent advances in the compound-oriented and pattern-oriented approaches to the quality control of herbal medicines.
  Zeng, Z., Chau, F. T., Chan, H. Y., Cheung, C. Y., Lau, T. Y., Wei, S., Mok, D. K., Chan, C. O., Liang, Y.> ;Chin Med. 2008
• Quantitative subtyping of hepatitis B virus reveals complex dynamics of YMDD motif mutants development during long-term lamivudine therapy.
  Ding, C., Wong, V. W., Chow, K. C., Chan, H. Y., Hui, A. Y., Wong, G. L., Lo, Y. M., Sung, J. J., Chan, H. L.> ;Antivir Ther (Lond). 2006
• Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
  Wong, V. W., Wong, G. L., Tsang, S. W., Hui, A. Y., Chim, A. M., Yiu, K. K., Chan, H. Y., Chan, F. K., Sung, J. J., Chan, H. L.> ;Antivir Ther (Lond). 2008
• Surrogate end points and long-term outcome in patients with chronic hepatitis B.
  Wong, V. W., Wong, G. L., Chim, A. M., Choi, P. C., Chan, A. W., Tsang, S. W., Hui, A. Y., Chan, H. Y., Sung, J. J., Chan, H. L.> ;Clin Gastroenterol Hepatol. 2009 Oct 01
• Hepatitis B virus infection and fatty liver in the general population.
  Wong, V. W., Wong, G. L., Chu, W. C., Chim, A. M., Ong, A., Yeung, D. K., Yiu, K. K., Chu, S. H., Chan, H. Y., Woo, J., Chan, F. K., Chan, H. L.> ;J Hepatol. 2012 Mar
• Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients.
  Chan, H. L., Wong, G. L., Tse, C. H., Chan, H. Y., Wong, V. W.> ;J Infect Dis. 2011 Aug 1
• Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B.
  Wong, V. W., Wong, G. L., Yiu, K. K., Chim, A. M., Chu, S. H., Chan, H. Y., Sung, J. J., Chan, H. L.> ;J Hepatol. 2011 Feb
• Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
  Wong, V. W., Wong, G. L., Choi, P. C., Chan, A. W., Li, M. K., Chan, H. Y., Chim, A. M., Yu, J., Sung, J. J., Chan, H. L.> ;Gut. 2010 Jul
• Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.
  Wong, V. W., Wong, G. L., Yan, K. K., Chim, A. M., Chan, H. Y., Tse, C. H., Choi, P. C., Chan, A. W., Sung, J. J., Chan, H. L.> ;Hepatology. 2010 Jun
• Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese.
  Wong, V. W., Wong, G. L., Yu, J., Choi, P. C., Chan, A. W., Chan, H. Y., Chu, E. S., Cheng, A. S., Chim, A. M., Chan, F. K., Sung, J. J., Chan, H. L.> ;Am J Gastroenterol. 2010 Jan 01
• Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastogra...
  Wong, G. L., Wong, V. W., Choi, P. C., Chan, A. W., Chim, A. M., Yiu, K. K., Chan, H. Y., Chan, F. K., Sung, J. J., Chan, H. L.> ;Am J Gastroenterol. 2008 Dec 01
• Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.
  Wong, G. L., Wong, V. W., Choi, P. C., Chan, A. W., Chim, A. M., Yiu, K. K., Chan, H. Y., Chan, F. K., Sung, J. J., Chan, H. L.> ;Clin Gastroenterol Hepatol. 2009 Feb 01
• Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: a seven-year follow-up study.
  Limquiaco, J. L., Wong, J., Wong, V. W., Wong, G. L., Tse, C. H., Chan, H. Y., Kwan, K. Y., Lai, P. B., Chan, H. L.> ;J Med Virol. 2009 Feb 01
• Treatment of patients with chronic hepatitis B who have failed previous antiviral treatment with pegylated interferon alpha2a (40 kda; PEGASYS).
  Chan, H. L., Wong, V. W., Chim, A. M., Wong, G. L., Chan, H. Y., Sung, J. J.> ;Antivir Ther (Lond). 2008
• Early hepatitis B virus DNA suppression can predict virologic response to peginterferon and lamivudine treatment.
  Chan, H. L., Wong, V. W., Wong, G. L., Chim, A. M., Chan, H. Y., Sung, J. J.> ;Clin Gastroenterol Hepatol. 2008 Sep
• Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.
  Chan, H. L., Wong, V. W., Tse, A. M., Tse, C. H., Chim, A. M., Chan, H. Y., Wong, G. L., Sung, J. J.> ;Clin Gastroenterol Hepatol. 2007 Dec
• Join now to see all